Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
To compare the incidence of preeclampsia in obese pregnant women (BMI greater than 30) with a
singleton gestation at less than 20 weeks and either a history of preeclampsia in a prior
pregnancy or stage I hypertension or pre-gestational diabetes who are randomized to either
81mg/day aspirin or 162mg/day aspirin.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston